Implementing allocation concealment

Implementing Allocation Concealment

Allocation concealment is a critical component in RCT design that prevents selection bias by ensuring that group assignment is not known prior to enrolling participants. Below are methods and best practices to implement allocation concealment effectively.

1. Use Centralized or Automated Randomization Systems

• Centralized Randomization: Allocation is controlled by a central office or secure web-based system, preventing investigators from predicting or manipulating assignments.
• Interactive Voice Response System (IVRS) or Interactive Web Response System (IWRS):
  • These systems automatically assign participants after eligibility confirmation.

Example: The investigator logs into a secure platform or calls an automated system. After confirming eligibility, the system returns the group assignment.

2. Use Sealed, Opaque, Sequentially Numbered Envelopes (SNOSE)

• Envelopes are pre-prepared with the randomization sequence.
• Precautions:
  • Must be opaque and tamper-proof.
  • Sequentially numbered.
  • Opened only after participant enrollment and eligibility confirmation.

Example: A trial coordinator opens envelope #023 after enrolling participant #23, revealing the treatment assignment inside.

3. Pharmacy-Controlled Randomization (for Drug Trials)

• The hospital or central pharmacy maintains the allocation list.
• Investigators request blinded study treatments from the pharmacy, which dispenses the correct intervention without revealing the allocation.

Example: The investigator requests "Study Drug" and the pharmacy dispenses the appropriate treatment/placebo based on the concealed sequence.

4. Use Pre-Numbered Study Kits or Devices

• Trial treatments (e.g., drug bottles or devices) are prepared and labeled according to a pre-randomized list.
• Investigators distribute the next available kit, maintaining concealment.

Example: Participants receive medication bottles labeled with a study number (e.g., #045), without knowing the group identity.

5. Independent Third-Party Allocation

• An independent person or team—unconnected to recruitment or clinical care—manages group assignment.

Example: A data manager controls the allocation list and communicates group assignments to the study team only after enrollment.

Best Practices

• Ensure allocation is concealed until participants are officially enrolled.
• Train all staff on the importance and techniques of allocation concealment.
• Implement regular monitoring and documentation to maintain integrity.

Common Pitfalls to Avoid

• Predictable Allocation: Avoid methods like alternation (e.g., every second participant assigned to control).
• Unsealed or Transparent Envelopes: Can be tampered with or held up to light to reveal contents.
• Investigator-Controlled Allocation: Increases risk of manipulation and selection bias.

Conclusion

Proper allocation concealment protects against bias, preserves trial integrity, and is a requirement for ethical and scientifically sound RCTs.

---

Bibliography

1. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. The Lancet. 2002;359(9306):614–618.
2. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
3. Higgins JPT, Thomas J, Chandler J, et al. (editors). Cochrane Handbook for Systematic Reviews of Interventions, version 6.3 (updated February 2022). Cochrane; 2022. Chapter 8: Assessing risk of bias in a randomized trial.
4. Devereaux PJ, Choi PT, El-Dika S, et al. An observational study found that authors of randomized controlled trials frequently use the term allocation concealment incorrectly. Journal of Clinical Epidemiology. 2005;58(7):662–664.

---

Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.